Your browser doesn't support javascript.
loading
Incorporating molecular profiling into endometrial cancer management requires prospective studies.
Amant, Frédéric; McCluggage, W Glenn; Werner, Henrica M J; Kasius, Jenneke C; Krakstad, Camilla; Pijnenborg, Johanna.
Affiliation
  • Amant F; Department of Oncology, KU Leuven, Leuven, Belgium frederic.amant@uzleuven.be.
  • McCluggage WG; Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Werner HMJ; Amsterdam University Medical Centres, Amsterdam, the Netherlands.
  • Kasius JC; Pathology, Belfast Health and Social Care Trust, Belfast, Belfast, UK.
  • Krakstad C; Department of Obstetrics and Gynaecology, GROW, Maastricht University School for Oncology & Developmental Biology, Maastricht, Limburg, Netherlands.
  • Pijnenborg J; Amsterdam University Medical Centres, Amsterdam, the Netherlands.
Int J Gynecol Cancer ; 31(6): 944-945, 2021 06.
Article in En | MEDLINE | ID: mdl-33962995
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Belgium
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Type of study: Observational_studies Limits: Female / Humans Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2021 Document type: Article Affiliation country: Belgium